Liao Y - Search Results

1

Safety and immunogenicity of Ad5-nCoV immunization after three-dose priming with inactivated SARS-CoV-2 vaccine in Chinese adults.

Zhang H, Xu N, Xu Y, Qin P, Dai R, Xu B, Wang S, Ding L, Fu J, Zhang S, Hua Q, Liao Y, Yang J, Hu X, Jiang J, Lv H. Zhang H, et al. Among authors: liao y. Nat Commun. 2023 Aug 8;14(1):4757. doi: 10.1038/s41467-023-40489-2. Nat Commun. 2023. PMID: 37553338 Free PMC article. Clinical Trial.

2

A Survey of Awareness of COVID-19 Knowledge, Willingness and Influencing Factors of COVID-19 Vaccination.

Yang J, Liao Y, Hua Q, Lv H. Yang J, et al. Among authors: liao y. Vaccines (Basel). 2022 Mar 28;10(4):524. doi: 10.3390/vaccines10040524. Vaccines (Basel). 2022. PMID: 35455273 Free PMC article.

3

Immunogenicity of a trivalent influenza vaccine and persistence of induced immunity in adults aged ≥60 years in Taizhou City, Zhejiang Province, China, during the 2018-2019 season.

Liao Y, Jin Y, Zhang H, Yang J, Fu J, Lv H. Liao Y, et al. Hum Vaccin Immunother. 2022 Nov 30;18(5):2071061. doi: 10.1080/21645515.2022.2071061. Epub 2022 Jun 10. Hum Vaccin Immunother. 2022. PMID: 35687101 Free PMC article.

4

Immunogenicity and immune-persistence of the CoronaVac or Covilo inactivated COVID-19 Vaccine: a 6-month population-based cohort study.

Hua Q, Zhang H, Yao P, Xu N, Sun Y, Lu H, Xu F, Liao Y, Yang J, Mao H, Zhang Y, Zhu H, Hu X, Lv H, Jiang J. Hua Q, et al. Among authors: liao y. Front Immunol. 2022 Aug 12;13:939311. doi: 10.3389/fimmu.2022.939311. eCollection 2022. Front Immunol. 2022. PMID: 36032136 Free PMC article.

5

Knowledge, attitudes, and practices toward COVID-19: A cross-sectional study during normal management of the epidemic in China.

Yang J, Liao Y, Hua Q, Sun C, Lv H. Yang J, et al. Among authors: liao y. Front Public Health. 2022 Sep 8;10:913478. doi: 10.3389/fpubh.2022.913478. eCollection 2022. Front Public Health. 2022. PMID: 36159311 Free PMC article.

6

Factors associated with neutralizing antibody levels induced by two inactivated COVID-19 vaccines for 12 months after primary series vaccination.

Wang F, Huang B, Lv H, Feng L, Ren W, Wang X, Tang L, Liu Q, Wu D, Zheng H, An Z, Deng Y, Zhao L, Ye F, Wang W, Zhang H, Chang S, Liao Y, Chen F, Rodewald LE, Gao GF, Yin Z, Tan W. Wang F, et al. Among authors: liao y. Front Immunol. 2022 Sep 9;13:967051. doi: 10.3389/fimmu.2022.967051. eCollection 2022. Front Immunol. 2022. PMID: 36159863 Free PMC article.

7

Safety and immunogenicity of heterologous recombinant protein subunit vaccine (ZF2001) booster against COVID-19 at 3-9-month intervals following two-dose inactivated vaccine (CoronaVac).

Liao Y, Chen Y, Chen B, Liang Z, Hu X, Xing B, Yang J, Zheng Q, Hua Q, Yan C, Lv H. Liao Y, et al. Front Immunol. 2022 Nov 8;13:1017590. doi: 10.3389/fimmu.2022.1017590. eCollection 2022. Front Immunol. 2022. PMID: 36426361 Free PMC article. Clinical Trial.

8

Evaluation of antibody kinetics and durability in healthy individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): A cross-sectional and cohort study in Zhejiang, China.

Zhang H, Hua Q, Nani Xu N, Zhang X, Chen B, Ma X, Hu J, Chen Z, Yu P, Lei H, Wang S, Ding L, Fu J, Liao Y, Yang J, Jiang J, Lv H. Zhang H, et al. Among authors: liao y. Elife. 2023 Mar 16;12:e84056. doi: 10.7554/eLife.84056. Elife. 2023. PMID: 36928099 Free PMC article.

9

Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older.

Chen Y, Zhang X, Gong L, Liang Z, Hu X, Xing B, Liao Y, Yuan L, Chen G, Lv H. Chen Y, et al. Among authors: liao y. Expert Rev Vaccines. 2023 Jan-Dec;22(1):1079-1090. doi: 10.1080/14760584.2023.2274491. Epub 2023 Nov 8. Expert Rev Vaccines. 2023. PMID: 37877219 Free article. Clinical Trial.

10

Identification and verification of a novel signature that combines cuproptosis-related genes with ferroptosis-related genes in osteoarthritis using bioinformatics analysis and experimental validation.

He B, Liao Y, Tian M, Tang C, Tang Q, Ma F, Zhou W, Leng Y, Zhong D. He B, et al. Among authors: liao y. Arthritis Res Ther. 2024 May 13;26(1):100. doi: 10.1186/s13075-024-03328-3. Arthritis Res Ther. 2024. PMID: 38741149

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

10,454 results

Search Page